Davenport & Co’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1K | Hold |
83,970
| – | – | ﹤0.01% | 1175 |
|
|
2025
Q1 | $4.2K | Hold |
83,970
| – | – | ﹤0.01% | 1139 |
|
|
2024
Q4 | $4.12K | Hold |
83,970
| – | – | ﹤0.01% | 1120 |
|
|
2024
Q3 | $4.03K | Hold |
83,970
| – | – | ﹤0.01% | 1111 |
|
|
2024
Q2 | $3.44K | Hold |
83,970
| – | – | ﹤0.01% | 1081 |
|
|
2024
Q1 | $4.62K | Hold |
83,970
| – | – | ﹤0.01% | 1077 |
|
|
2023
Q4 | $7.56K | Sell |
83,970
-7,000
| -8% | -$630 | ﹤0.01% | 1034 |
|
|
2023
Q3 | $8.64K | Hold |
90,970
| – | – | ﹤0.01% | 1025 |
|
|
2023
Q2 | $10K | Sell |
90,970
-2,800
| -3% | -$308 | ﹤0.01% | 1028 |
|
|
2023
Q1 | $11.8K | Hold |
93,770
| – | – | ﹤0.01% | 1013 |
|
|
2022
Q4 | $11K | Hold |
93,770
| – | – | ﹤0.01% | 979 |
|
|
2022
Q3 | $13K | Hold |
93,770
| – | – | ﹤0.01% | 969 |
|
|
2022
Q2 | $13K | Hold |
93,770
| – | – | ﹤0.01% | 963 |
|
|
2022
Q1 | $14K | Sell |
93,770
-967
| -1% | -$144 | ﹤0.01% | 1034 |
|
|
2021
Q4 | $18K | Sell |
94,737
-1,833
| -2% | -$348 | ﹤0.01% | 1045 |
|
|
2021
Q3 | $21K | Buy |
96,570
+2,800
| +3% | +$609 | ﹤0.01% | 1022 |
|
|
2021
Q2 | $23K | Hold |
93,770
| – | – | ﹤0.01% | 940 |
|
|
2021
Q1 | $20K | Hold |
93,770
| – | – | ﹤0.01% | 796 |
|
|
2020
Q4 | $33K | Hold |
93,770
| – | – | ﹤0.01% | 778 |
|
|
2020
Q3 | $37K | Hold |
93,770
| – | – | ﹤0.01% | 728 |
|
|
2020
Q2 | $39K | Sell |
93,770
-21,100
| -18% | -$8.78K | ﹤0.01% | 698 |
|
|
2020
Q1 | $54K | Hold |
114,870
| – | – | ﹤0.01% | 644 |
|
|
2019
Q4 | $52K | Buy |
+114,870
| New | +$52K | ﹤0.01% | 717 |
|